Former studies of Shabo and colleagues already demonstrated that breast cancer expression of CD163 was correlated to early distant recurrence and reduced patient survival [59], which further indicates that tumor hybrid cells could be more malignant than parental type tumor cells. This evidence concerns the gene CD163 and breast carcinoma.